225 related articles for article (PubMed ID: 25168214)
1. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Mandel JJ; Yust-Katz S; Cachia D; Wu J; Liu D; de Groot JF; Yung AW; Gilbert MR
J Neurooncol; 2014 Dec; 120(3):597-605. PubMed ID: 25168214
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience.
Andersen BM; Miranda C; Hatzoglou V; DeAngelis LM; Miller AM
Neurology; 2019 May; 92(21):e2483-e2491. PubMed ID: 31019097
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal disease in glioblastoma: endgame or opportunity?
Akmal S; Ginalis EE; Patel NV; Aiken R; Dicpinigaitis AJ; Hanft SJ
J Neurooncol; 2021 Nov; 155(2):107-115. PubMed ID: 34623599
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
[TBL] [Abstract][Full Text] [Related]
5. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
6. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome.
Noh JH; Lee MH; Kim WS; Lim DH; Kim ST; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2015 Apr; 157(4):569-76. PubMed ID: 25663100
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
[TBL] [Abstract][Full Text] [Related]
8. Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination.
You HJ; Park HY; Kim J; Lee IH; Seol HJ; Lee JI; Kim ST; Kong DS; Nam DH
Medicine (Baltimore); 2016 Jul; 95(27):e4109. PubMed ID: 27399113
[TBL] [Abstract][Full Text] [Related]
9. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
[TBL] [Abstract][Full Text] [Related]
10. Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution.
Tsung AJ; Prabhu SS; Lei X; Chern JJ; Benjamin Bekele N; Shonka NA
J Neurooncol; 2011 Dec; 105(3):555-62. PubMed ID: 21643841
[TBL] [Abstract][Full Text] [Related]
11. Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination.
Mazloom A; Hodges JC; Teh BS; Chintagumpala M; Paulino AC
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):350-4. PubMed ID: 22401918
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal disease in pancreas ductal adenocarcinoma: A manifestation of longevity.
O'Connor CA; Park JS; Kaley T; Kezlarian B; Edelweiss M; Yang TJ; Park W; Reidy D; Varghese AM; Yu KH; O'Reilly EM
Pancreatology; 2021 Apr; 21(3):599-605. PubMed ID: 33582005
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu HG; Curran WJ; Crocker IR; Patel KR
Neurosurgery; 2019 Nov; 85(5):632-641. PubMed ID: 30335175
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.
Wolf A; Donahue B; Silverman JS; Chachoua A; Lee JK; Kondziolka D
J Neurooncol; 2017 Aug; 134(1):139-143. PubMed ID: 28536993
[TBL] [Abstract][Full Text] [Related]
15. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
[TBL] [Abstract][Full Text] [Related]
16. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact.
Kim H; Lim DH; Kim TG; Lee JI; Nam DH; Seol HJ; Kong DS; Choi JW; Suh YL; Kim ST
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e366-e373. PubMed ID: 29473335
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
Roldán G; Scott J; George D; Parney I; Easaw J; Cairncross G; Forsyth P; Yan E
Can J Neurol Sci; 2008 May; 35(2):204-9. PubMed ID: 18574935
[TBL] [Abstract][Full Text] [Related]
20. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]